dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid

C296H525Cl3K2N6O44S — CID 160712130

IUPACdipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid
SMILESCCCCCCCCCCCCCCCCCCOc1cc(C(=O)O)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOc1cc(C(=O)OCCl)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOc1cc(C(=O)OCn2c(=O)c(C)cn([C@H]3CC(OC(=O)CCC(C)=O)[C@@H](CC)O3)c2=O)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOc1cc(C(=O)OCn2c(=O)c(C)cn([C@H]3CC(OC(=O)CCC(C)=O)[C@@H](CO)O3)c2=O)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)CC1OC(=O)CCC(C)=O.O=CO[O-].O=S(=O)(Cl)CCl.[H-].[K+].[K+]
InChIInChI=1S/C78H136N2O11.C77H134N2O12.C62H115ClO5.C61H114O5.C16H22N2O6.CH2Cl2O2S.CH2O3.2K.H/c1-7-11-14-17-20-23-26-29-32-35-38-41-44-47-50-53-58-86-71-61-68(77(84)89-65-80-76(83)66(5)64-79(78(80)85)73-63-70(69(10-4)90-73)91-74(82)57-56-67(6)81)62-72(87-59-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-8-2)75(71)88-60-55-52-49-46-43-40-37-34-31-28-25-22-19-16-13-9-3;1-6-9-12-15-18-21-24-27-30-33-36-39-42-45-48-51-56-86-69-59-67(76(84)89-64-79-75(83)65(4)62-78(77(79)85)72-61-68(71(63-80)90-72)91-73(82)55-54-66(5)81)60-70(87-57-52-49-46-43-40-37-34-31-28-25-22-19-16-13-10-7-2)74(69)88-58-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-3;1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-52-65-59-55-58(62(64)68-57-63)56-60(66-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2)61(59)67-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3;1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-52-64-58-55-57(61(62)63)56-59(65-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2)60(58)66-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3;1-4-11-12(24-14(20)6-5-10(3)19)7-13(23-11)18-8-9(2)15(21)17-16(18)22;2-1-6(3,4)5;2-1-4-3;;;/h61-62,64,69-70,73H,7-60,63,65H2,1-6H3;59-60,62,68,71-72,80H,6-58,61,63-64H2,1-5H3;55-56H,4-54,57H2,1-3H3;55-56H,4-54H2,1-3H3,(H,62,63);8,11-13H,4-7H2,1-3H3,(H,17,21,22);1H2;1,3H;;;/q;;;;;;;2*+1;-1/p-1/t69-,70?,73-;68?,71-,72-;;;11-,12?,13-;;;;;/m11..1...../s1
InChIKeyYHZCOMINCOUUFW-GRTZHPDVSA-M
MW5089.08 g/mol
LogP80.04
Rot. Bonds245

About dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid

dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid (PubChem CID 160712130) has the molecular formula C296H525Cl3K2N6O44S and a molecular weight of 5089.08 g/mol. Its IUPAC name is dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid.

Molecular Properties

Compound Namedipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid
PubChem CID160712130
Molecular FormulaC296H525Cl3K2N6O44S
Molecular Weight5089.08 g/mol
Exact Mass5083.71
IUPAC Namedipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid
SMILESCCCCCCCCCCCCCCCCCCOc1cc(C(=O)O)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOc1cc(C(=O)OCCl)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOc1cc(C(=O)OCn2c(=O)c(C)cn([C@H]3CC(OC(=O)CCC(C)=O)[C@@H](CC)O3)c2=O)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOc1cc(C(=O)OCn2c(=O)c(C)cn([C@H]3CC(OC(=O)CCC(C)=O)[C@@H](CO)O3)c2=O)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)CC1OC(=O)CCC(C)=O.O=CO[O-].O=S(=O)(Cl)CCl.[H-].[K+].[K+]
InChIInChI=1S/C78H136N2O11.C77H134N2O12.C62H115ClO5.C61H114O5.C16H22N2O6.CH2Cl2O2S.CH2O3.2K.H/c1-7-11-14-17-20-23-26-29-32-35-38-41-44-47-50-53-58-86-71-61-68(77(84)89-65-80-76(83)66(5)64-79(78(80)85)73-63-70(69(10-4)90-73)91-74(82)57-56-67(6)81)62-72(87-59-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-8-2)75(71)88-60-55-52-49-46-43-40-37-34-31-28-25-22-19-16-13-9-3;1-6-9-12-15-18-21-24-27-30-33-36-39-42-45-48-51-56-86-69-59-67(76(84)89-64-79-75(83)65(4)62-78(77(79)85)72-61-68(71(63-80)90-72)91-73(82)55-54-66(5)81)60-70(87-57-52-49-46-43-40-37-34-31-28-25-22-19-16-13-10-7-2)74(69)88-58-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-3;1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-52-65-59-55-58(62(64)68-57-63)56-60(66-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2)61(59)67-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3;1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-52-64-58-55-57(61(62)63)56-59(65-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2)60(58)66-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3;1-4-11-12(24-14(20)6-5-10(3)19)7-13(23-11)18-8-9(2)15(21)17-16(18)22;2-1-6(3,4)5;2-1-4-3;;;/h61-62,64,69-70,73H,7-60,63,65H2,1-6H3;59-60,62,68,71-72,80H,6-58,61,63-64H2,1-5H3;55-56H,4-54,57H2,1-3H3;55-56H,4-54H2,1-3H3,(H,62,63);8,11-13H,4-7H2,1-3H3,(H,17,21,22);1H2;1,3H;;;/q;;;;;;;2*+1;-1/p-1/t69-,70?,73-;68?,71-,72-;;;11-,12?,13-;;;;;/m11..1...../s1
InChIKeyYHZCOMINCOUUFW-GRTZHPDVSA-M
XLogP80.04
TPSA631.35 Ų
H-Bond Donors3
H-Bond Acceptors48
Rotatable Bonds245
Heavy Atoms352
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5005089.08
LogP ≤ 580.04
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1048

Analyze dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(2R,3R,5R)-5-[3-[2,3-di(icosoxy)benzoyl]-5-methyl-2,4-dioxopyrimidin-1-yl]-2-(hydroxymethyl)oxolan-3-yl] 4-oxopentanoate
CID 118490289
[2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] butanoate
CID 5301664
[(2R,3R,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] butanoate
CID 11898979
4-[2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-4-oxobutanoic acid
CID 167668198
4-O-[2-[[[2-[[[2-(hydroxymethyl)-5-(6-methylpurin-9-yl)oxolan-3-yl]oxy-(2-isocyanoethoxy)phosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-(2-isocyanoethoxy)phosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 1-O-[(3,4,5-trioctadecoxyphenyl)methyl] butanedioate
CID 159480245
[(2R,3R,5S)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] acetate
CID 26236818
[(2R,3S,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxo-4-[2-[(3,4,5-trioctadecoxybenzoyl)amino]ethylamino]butanoate
CID 102100226
[5-(5-bromo-2,4-dioxopyrimidin-1-yl)-2-ethyloxolan-3-yl] 4-oxopentanoate
CID 58021760
4-O-[2-[2-cyanoethoxy-[(2R,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphoryl]oxyethyl] 1-O-[2-[methyl-(3,4,5-trioctadecoxybenzoyl)amino]ethyl] butanedioate
CID 156662957
[(2R,3S,5R)-2-(azidooxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] hexadecanoate
CID 54175678
[(2R,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] octyl hydrogen phosphate
CID 102192256
[(2R,3S,5R)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2-(methylsulfanylmethoxymethyl)oxolan-3-yl] 4-oxopentanoate
CID 123229798

Frequently Asked Questions

What is the IUPAC name of dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid?
The IUPAC name of dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid (CID 160712130) is dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid.
What is the SMILES notation for dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid?
The canonical SMILES for dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid is CCCCCCCCCCCCCCCCCCOc1cc(C(=O)O)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOc1cc(C(=O)OCCl)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOc1cc(C(=O)OCn2c(=O)c(C)cn([C@H]3CC(OC(=O)CCC(C)=O)[C@@H](CC)O3)c2=O)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOc1cc(C(=O)OCn2c(=O)c(C)cn([C@H]3CC(OC(=O)CCC(C)=O)[C@@H](CO)O3)c2=O)cc(OCCCCCCCCCCCCCCCCCC)c1OCCCCCCCCCCCCCCCCCC.CC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)CC1OC(=O)CCC(C)=O.O=CO[O-].O=S(=O)(Cl)CCl.[H-].[K+].[K+].
What is the InChIKey of dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid?
The InChIKey is YHZCOMINCOUUFW-GRTZHPDVSA-M. The full InChI is InChI=1S/C78H136N2O11.C77H134N2O12.C62H115ClO5.C61H114O5.C16H22N2O6.CH2Cl2O2S.CH2O3.2K.H/c1-7-11-14-17-20-23-26-29-32-35-38-41-44-47-50-53-58-86-71-61-68(77(84)89-65-80-76(83)66(5)64-79(78(80)85)73-63-70(69(10-4)90-73)91-74(82)57-56-67(6)81)62-72(87-59-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-8-2)75(71)88-60-55-52-49-46-43-40-37-34-31-28-25-22-19-16-13-9-3;1-6-9-12-15-18-21-24-27-30-33-36-39-42-45-48-51-56-86-69-59-67(76(84)89-64-79-75(83)65(4)62-78(77(79)85)72-61-68(71(63-80)90-72)91-73(82)55-54-66(5)81)60-70(87-57-52-49-46-43-40-37-34-31-28-25-22-19-16-13-10-7-2)74(69)88-58-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-3;1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-52-65-59-55-58(62(64)68-57-63)56-60(66-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2)61(59)67-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3;1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-52-64-58-55-57(61(62)63)56-59(65-53-50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2)60(58)66-54-51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3;1-4-11-12(24-14(20)6-5-10(3)19)7-13(23-11)18-8-9(2)15(21)17-16(18)22;2-1-6(3,4)5;2-1-4-3;;;/h61-62,64,69-70,73H,7-60,63,65H2,1-6H3;59-60,62,68,71-72,80H,6-58,61,63-64H2,1-5H3;55-56H,4-54,57H2,1-3H3;55-56H,4-54H2,1-3H3,(H,62,63);8,11-13H,4-7H2,1-3H3,(H,17,21,22);1H2;1,3H;;;/q;;;;;;;2*+1;-1/p-1/t69-,70?,73-;68?,71-,72-;;;11-,12?,13-;;;;;/m11..1...../s1.
What are the key properties of dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid?
dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid has a molecular weight of 5089.08 g/mol, XLogP of 80.04, 245 rotatable bonds, 3 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;chloromethanesulfonyl chloride;chloromethyl 3,4,5-trioctadecoxybenzoate;[(2R,5R)-2-ethyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] 4-oxopentanoate;[3-[(2R,5R)-5-ethyl-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;hydride;[3-[(2R,5R)-5-(hydroxymethyl)-4-(4-oxopentanoyloxy)oxolan-2-yl]-5-methyl-2,6-dioxopyrimidin-1-yl]methyl 3,4,5-trioctadecoxybenzoate;oxido formate;3,4,5-trioctadecoxybenzoic acid is sourced from PubChem (CID 160712130), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).